cagrilintide and semaglutide Clinical trials of subcutaneous tirzepatide, retatrutide, Cagrilintide–semaglutide (CagriSema) as an add-on

Timing exercise relative to tirzepatide injections affects tolerability

It accelerates fat loss, enhances muscle recovery, and supports overall fitness goals

Jun 15 2018;4(4):323-333

Factors like what you ate for breakfast, your stomach acid levels, and even your individual gut health all play a role

The biggest known risks are retatrutide-driven GI side effects (nausea 38-43%, diarrhea 33-35%) and dysesthesia - an unusual skin tingling or burning sensation at higher doses

Information provided by Blue Cross and Blue Shield of Illinois is for informational and educational purposes only and is not a substitute for the independent medical judgment of a physician or other health care provider, nor is the information presented intended to replace or supersede any requirements set forth in your contract with BCBSIL